These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 34008212)
1. S100A6 represses Calu-6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis. Wang T; Han S; Du G Cell Biochem Funct; 2021 Aug; 39(6):771-779. PubMed ID: 34008212 [TBL] [Abstract][Full Text] [Related]
2. S100A6 could not promote the differentiation of Calu-6 lung cancer cell line. Li J; Wang T; Dang D Ann Med Surg (Lond); 2024 May; 86(5):2644-2650. PubMed ID: 38694326 [TBL] [Abstract][Full Text] [Related]
4. S100A6 promotes the development of thyroid cancer and inhibits apoptosis of thyroid cancer cells through the PI3K/AKT/mTOR pathway. Chen B; Zheng D; Liu C; Bhandari A; Hirachan S; Shen C; Mainali S; Li H; Jiang W; Xu J; Zhang X; Tang K; Zhang W Pathol Res Pract; 2023 Feb; 242():154325. PubMed ID: 36680929 [TBL] [Abstract][Full Text] [Related]
5. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation. Li Y; Wagner ER; Yan Z; Wang Z; Luther G; Jiang W; Ye J; Wei Q; Wang J; Zhao L; Lu S; Wang X; Mohammed MK; Tang S; Liu H; Fan J; Zhang F; Zou Y; Song D; Liao J; Haydon RC; Luu HH; He TC Cell Physiol Biochem; 2015; 37(6):2375-92. PubMed ID: 26646427 [TBL] [Abstract][Full Text] [Related]
6. S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer. Zhang J; Zhang K; Jiang X; Zhang J Dig Dis Sci; 2014 Sep; 59(9):2136-44. PubMed ID: 24705642 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of S100A6 in patients with endometriosis and its role in ectopic endometrial stromal cells. Peng Y; Lin J; Ma J; Lin K; Xu K; Lin J Gynecol Endocrinol; 2018 Sep; 34(9):815-820. PubMed ID: 29544367 [TBL] [Abstract][Full Text] [Related]
8. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential. Yang F; Ma J; Zhu D; Wang Z; Li Y; He X; Zhang G; Kang X Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509175 [TBL] [Abstract][Full Text] [Related]
9. [Regulation mechanism study of S100A6 on invasion and metastasis in gastric cancer]. Li J; Wang XH; Li ZY; Bu ZD; Wu AW; Zhang LH; Wu XJ; Zong XL; Ji JF Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1096-101. PubMed ID: 24277409 [TBL] [Abstract][Full Text] [Related]
10. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway. Zheng S; Shen H; Jia Q; Jing C; Lin J; Zhang M; Zhang X; Zhang B; Liu Y Future Oncol; 2017 Oct; 13(23):2053-2063. PubMed ID: 28984474 [TBL] [Abstract][Full Text] [Related]
11. S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling. Lerchenmüller C; Heißenberg J; Damilano F; Bezzeridis VJ; Krämer I; Bochaton-Piallat ML; Hirschberg K; Busch M; Katus HA; Peppel K; Rosenzweig A; Busch H; Boerries M; Most P Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1854-67. PubMed ID: 27386938 [TBL] [Abstract][Full Text] [Related]
12. S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy. Qi M; Yi X; Yue B; Huang M; Zhou S; Xiong J Breast Cancer Res; 2023 May; 25(1):55. PubMed ID: 37217945 [TBL] [Abstract][Full Text] [Related]
13. Current view on cellular function of S100A6 and its ligands, CacyBP/SIP and Sgt1. Filipek A; Leśniak W Postepy Biochem; 2018 Oct; 64(3):242-252. PubMed ID: 30656909 [TBL] [Abstract][Full Text] [Related]
14. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein. Sung HY; Dowarha D; Chou RH; Yu C Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253 [TBL] [Abstract][Full Text] [Related]
15. Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling. Orre LM; Pernemalm M; Lengqvist J; Lewensohn R; Lehtiö J Mol Cell Proteomics; 2007 Dec; 6(12):2122-31. PubMed ID: 17785350 [TBL] [Abstract][Full Text] [Related]
16. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma. Onsurathum S; Haonon O; Pinlaor P; Pairojkul C; Khuntikeo N; Thanan R; Roytrakul S; Pinlaor S Tumour Biol; 2018 Apr; 40(4):1010428318767195. PubMed ID: 29629840 [TBL] [Abstract][Full Text] [Related]
17. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line. Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022 [TBL] [Abstract][Full Text] [Related]
18. Interaction of S100A6 with Target Proteins In Vitro and in Living Cells. Sakane K; Yamaguchi F; Tsuchiya M; Kondo R; Kanayama N; Magari M; Hatano N; Kobayashi R; Tokumitsu H Methods Mol Biol; 2019; 1929():367-377. PubMed ID: 30710285 [TBL] [Abstract][Full Text] [Related]
19. High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer. He X; Xu X; Khan AQ; Ling W Med Sci Monit; 2017 Oct; 23():5011-5017. PubMed ID: 29053662 [TBL] [Abstract][Full Text] [Related]
20. Effects of S100A6 gene silencing on the biological features of eutopic endometrial stromal cells and β‑catenin expression. Zhang X; Liu Z; Chen M; Cao Q; Huang D Mol Med Rep; 2017 Mar; 15(3):1279-1285. PubMed ID: 28075439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]